Metformin accumulation without hyperlactataemia and metformin-induced hyperlactataemia without metformin accumulation

Diabetes and Metabolism

Volumn 40, Issue 3, 2014, Pages 220-223

  Lalau, J D ^a,b   Azzoug, M L ^a   Kajbaf, F ^a,b   Briet, C ^c   Desailloud, R ^a,b  

^a AMIENS UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE PICARDIE JULES VERNE   (France)

^c BICÊTRE HOSPITAL   (France)

Author keywords

Hyperlactataemia; Lactate; Lactic acidosis; Metformin; Type 2 diabetes

Indexed keywords

AMOXICILLIN; BENZODIAZEPINE; BICARBONATE; CREATININE; FLUMAZENIL; FUROSEMIDE; INSULIN; LACTIC ACID; METFORMIN; NITROGEN; UREA; ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; CASE REPORT; CONFUSION; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG INDUCED DISEASE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPNEA; FEMALE; FEVER; GAIT DISORDER; GLASGOW COMA SCALE; HEMODIALYSIS; HUMAN; HYPERLACTATEMIA; INTENSIVE CARE UNIT; KIDNEY FAILURE; LACTATE BLOOD LEVEL; LACTIC ACIDOSIS; MALE; METABOLIC ACIDOSIS; METFORMIN INDUCED HYPERLACTATEMIA; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; SEVERE RENAL IMPAIRMENT; UREA NITROGEN BLOOD LEVEL; BLOOD; CHEMICALLY INDUCED; DIABETES MELLITUS, TYPE 2; DRUG ADMINISTRATION; DRUG HYPERSENSITIVITY; DRUG RESISTANCE; METABOLISM; TREATMENT OUTCOME;

ACIDOSIS, LACTIC; AGED; DIABETES MELLITUS, TYPE 2; DRUG ADMINISTRATION SCHEDULE; DRUG HYPERSENSITIVITY; DRUG RESISTANCE; FEMALE; HUMANS; HYPERLACTATEMIA; HYPOGLYCEMIC AGENTS; LACTIC ACID; MALE; METFORMIN; MIDDLE AGED; TREATMENT OUTCOME;

EID: 84902550389     PISSN: 12623636     EISSN: 18781780     Source Type: Journal    
DOI: 10.1016/j.diabet.2013.12.003     Document Type: Article

References (10)

1. Dell'Aglio D.M., Perino L.J., Kazzi Z., Abramson J., Schwartz M.D., Morgan B.W. Acute metformin overdose: examining serum pH, lactate level, and metformin concentrations in survivors versus nonsurvivors: a systematic review of the literature. Ann Emerg Med 2009, 54:818-823.
2. Lalau J., Race J.M. Lactic acidosis in metformin therapy: searching for a link with metformin in reports of 'metformin-associated lactic acidosis'. Diabetes Obes Metab 2001, 3:195-201.
3. Vernon C., Letourneau J.L. Lactic acidosis: recognition, kinetics, and associated prognosis. Crit Care Clin 2010, 26:255-283.
4. Luft D., Deichsel G., Schmulling R., Stein N., Eggstein M. Definition of clinically relevant lactic acidosis in patients with internal diseases. Am J Clin Pathol 1983, 80:484-489.
5. Lalau J., Lacroix C. Measurement of metformin concentration in erythrocytes: clinical implications. Diabetes Obes Metab 2003, 5:92-98.
6. Laragh J.H. Relation of aldosterone secretion to hypertensive vascular disease. Circ Res 1961, 9:792-804.
7. Gong L., Goswami S., Giacomini K.M., Altman R.B., Klein T.E. Metformin pathways: pharmacokinetics and pharmacodynamics. Pharmacogenet Genomics 2012, 22:820-827.
8. Zolk O. Disposition of metformin: variability due to polymorphisms of organic cation transporters. Ann Med 2012, 44:119-129.
9. Radziuk J., Zhang Z., Wiernsperger N., Pye S. Effects of metformin on lactate uptake and gluconeogenesis in the perfused rat liver. Diabetes 1997, 46:1406-1413.
10. Christensen M.M., Brasch-Andersen C., Green H., Nielsen F., Damkier P., Beck-Nielsen H., et al. The pharmacogenetics of metformin and its impact on plasma metformin steady-state levels and glycosylated hemoglobin A1c. Pharmacogenet Genomics 2011, 21:837-850.